Synthesis of Chromone‐3‐phosphonates via Arbuzov‐Type C−P Cross Coupling from o ‐Hydroxyphenyl Enaminones and Phosphites
Advanced Synthesis & Catalysis · 03.09.2024 · 366 (17) · 3670-3675
DOI: 10.1002/adsc.202400587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Synthesis & Catalysis, online erschienen am 22.08.2024. Verfasst von Dingsheng Cao und 2 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
With an in situ C−H iodination tactic, a method for the synthesis of chromone‐3‐phosphonates was developed with trialkyl/triaryl phosphites as the reaction partners of o ‐hydroxyphenyl enaminones by palladium catalysis. The product formation consists of cascade C−H iodination, chromone annulation, and Arbuzov‐type C−P cross coupling as major transformations. In addition to providing an enaminone‐based synthetic method to chromone‐3‐phosphonates, the work shows the advantage of step economy by skipping the separate operation for preparing the iodo‐functionalized chromone intermediate.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cao, D., Wan, J., & Liu, Y. (2024). Synthesis of Chromone‐3‐phosphonates via Arbuzov‐Type C−P Cross Coupling from o ‐Hydroxyphenyl Enaminones and Phosphites. Advanced Synthesis & Catalysis, 366(17), 3670-3675. https://doi.org/10.1002/adsc.202400587
Vancouver
Cao D, Wan J, Liu Y. Synthesis of Chromone‐3‐phosphonates via Arbuzov‐Type C−P Cross Coupling from o ‐Hydroxyphenyl Enaminones and Phosphites. Advanced Synthesis & Catalysis. 2024;366(17):3670-3675. doi:10.1002/adsc.202400587
BibTeX
@article{Cao2024,
author = {Cao, Dingsheng and Wan, Jie‐Ping and Liu, Yunyun},
title = {Synthesis of Chromone‐3‐phosphonates via Arbuzov‐Type C−P Cross Coupling from o ‐Hydroxyphenyl Enaminones and Phosphites},
journal = {Advanced Synthesis & Catalysis},
year = {2024},
volume = {366},
number = {17},
pages = {3670--3675},
doi = {10.1002/adsc.202400587}
}
EUVIMED